As of march 31, 2015, cash and equivalent is $18.50m or $1.52/share. With its good financial position coupled with this great news of the liver cancer drug--the CHEMOSAT, this is a 6 bagger in short term.
Sentiment: Strong Buy
Investors who got trapped in the 3's and 4's by the fake news yesterday will speak out and sue the company soon. ppa gapped up to 3.80 and shot up to 4.35 from previous close of 3.15 by the fake news that caused many investors trapped by it, not fair. Lawsuits are pending for sure.
I said it was fake because It was the news of the past. But pps was gapped up at 3.80 and shot up to 4.35 by this fake news, not fair for those got trapped by it. Lawsuits are pending, just wait and see.